EA
PFE icon

Euclid Advisors’s Pfizer PFE Stock Holding History

Euclid Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-244,182
Closed -$8.16M – 346
2016
Q2 		$8.16M Buy
244,182
+118,933
+95% +$3.8M 0.35% 101
2016
Q1 		$3.52M Sell
125,249
-226,181
-64% -$6.46M 0.13% 223
2015
Q4 		$10.8M Buy
+351,430
New +$11.1M 0.33% 101
2015
Q3 		– Sell
-514,133
Closed -$16.4M – 387
2015
Q2 		$16.4M Sell
514,133
-1,837,657
-78% -$59.9M 0.32% 97
2015
Q1 		$77.6M Buy
+2,351,790
New +$74.8M 1.43% 11
2014
Q4 		– Sell
-3,399,666
Closed -$95.4M – 468
2014
Q3 		$95.4M Buy
3,399,666
+206,562
+6% +$5.8M 0.68% 22
2014
Q2 		$89.9M Sell
3,193,104
-520,142
-14% -$14.8M 0.63% 29
2014
Q1 		$113M Buy
3,713,246
+976,341
+36% +$29.1M 0.85% 20
2013
Q4 		$79.5M Sell
2,736,905
-195,981
-7% -$5.7M 0.66% 25
2013
Q3 		$79.9M Buy
2,932,886
+584,159
+25% +$15.9M 0.81% 18
2013
Q2 		$62.4M Buy
+2,348,727
New +$64.9M 0.79% 18

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Euclid Advisors's PFE Position: Q3 2016 in Review

Euclid Advisors sold out of Pfizer (PFE) in Q3 2016, closing a stake of 244,182 shares — an estimated $8.16M sold.

Euclid Advisors first reported a position in PFE in Q2 2013 and held it in 11 quarters. The position peaked at $113M in Q1 2014. 1,963 funds tracked by Wall St. Rank hold PFE as of Q3 2016.

  • Euclid Advisors reported no remaining Pfizer position as of Q3 2016 after selling out during the quarter.
  • Euclid Advisors sold 244,182 Pfizer shares in Q3 2016, an estimated $8.16M.
  • Euclid Advisors first reported a position in Pfizer in Q2 2013 and held it in 11 quarters.
  • Euclid Advisors's Pfizer position peaked at $113M in Q1 2014.
  • 1,963 funds tracked by Wall St. Rank held Pfizer as of Q3 2016.

Based on Euclid Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.